euro-cancer-2018-scientifictracks

9 / 36

Page 53
conferenceseries.com
Volume 10 Journal of Cancer Science & Therapy
ISSN: 1948-5956 Euro Cancer 2018
July 23-25, 2018
July 23-25, 2018 | Rome, Italy
29th Euro-Global Summit on
Cancer Therapy & Radiation Oncology
EGF and TGFα motogenic activities are mediated by the EGF receptor: Identification of the signaling
pathways involved in oral cancer
Aye Myat Thwe
University of Dundee, UK
Epithelial to mesenchymal transition (EMT) is the process by which cells change shape from being tightly connected
epithelial cells to more motile mesenchymal cells. EMT has been reported to facilitate cancer cell migration. Cell motility
is an initial first step on the road to metastasis. Epidermal growth factor (EGFR) has been reported to be overexpressed in oral
cancer and is often related with poor prognosis. Epidermal growth factor (EGF) and transforming growth factorα (TGFα)
are ligands that bind to EGFR and can affect a number of different cellular processes, including cell proliferation, migration,
angiogenesis and inhibition of apoptosis. We aimed to measure proliferation, migration, morphology change of HSG, AZA1,
HaCaT, TYS, by cell counting, photo microscopic image capturing and scratch assay in relation with addition of growth factors
at 1 ng/ml, 10 ng/ml, 50 ng/ml and 24 hrs, 48 hrs, 72 hrs. 50 ng/ml of growth factors induce cell morphology changes EMT like
phenotype with finger like projection, cell scattering and increase cell migration while no reliable different in cell proliferation.
These morphology changes are completely blocked by one hour pre-treatment with 5 µM gefitinib (EGFR tyrosine kinase
inhibitor, 5 µM erlotinib (EGFR kinase inhibitor) and PD25 µM ( inhibitors of MEK1 and MAKP kinase) in HSG and AZA1
cell lines. The cell migration of TYS and HSG cell lines are completely blocked by one hour pre-treatment with one hour
pre-treatment with 5 µM gefitinib (EGFR tyrosine kinase inhibitor, 5 µM erlotinib (EGFR kinase inhibitor) and PD25 µM
(inhibitors of MEK1 and MAKP kinase).
Figure 1: EGFR signaling in oral cancer.
Biography
Aye Myat Thwe graduated from Myanmar with a Bachelor of Dental Surgery in 2010. After practicing as a Dentist for two years, she came to UK to study at University of
Dundee. She received an MRes in Oral Cancer, and progressed into the PhD programme. She is now in the 3rd year of her PhD programme.
Aye Myat Thwe, J Cancer Sci Ther 2018, Volume 10
DOI: 10.4172/1948-5956-C8-144